Investment Opportunities

Mycleanium operates in the emerging sector of mycelium-based biotechnology, applying proprietary fungal systems to environmental remediation. Our platform enables hydrocarbon degradation and heavy metal immobilization with potential cost savings of up to 40% compared to traditional methods, addressing the $14+ billion annual remediation market within the mining and energy industries.

Led by a team with extensive experience in biotechnology and environmental services, our technology is grounded in peer-reviewed scientific research demonstrating that mycoremediation can achieve 80% contaminant reduction. Mycelium-based technologies have broad applicability across sectors including materials science, agriculture, healthcare, and environmental services—representing a potential $100+ billion market opportunity.

We are currently raising capital to advance our technology and are engaging with qualified accredited investors and strategic partners under applicable exemptions. All investment discussions are conducted in compliance with relevant securities regulations in the jurisdictions in which we operate.

This material does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any such offer will be made only by means of formal offering documents and in accordance with applicable laws. Investment involves risk, including the potential loss of principal. This document contains forward-looking statements that involve risks and uncertainties.